January 26, 2017 — Accuray Inc. announced recently that Miami Cancer Institute, a part of Baptist Health South Florida, is now treating patients using the new Radixact Treatment Delivery System, fully integrated with the new Accuray Precision Treatment Planning System and iDMS Data Management System.
Miami Cancer Institute selected the Radixact platform for its new, state-of-the-art treatment center because it offers advanced treatment faster and expands access for more patients, while providing the foundation for anticipated clinical capabilities in the future.
"Miami Cancer Institute has achieved an important milestone with these first patient treatments. We are making meaningful progress toward our goal to offer advanced, comprehensive radiation therapy to our patients," said Minesh P. Mehta, M.D., deputy director and chief of radiation oncology at Miami Cancer Institute. "We set an aggressive schedule for the treatments on the first day and were able to successfully treat all patients, in less time than planned. Our team was extremely impressed with this performance, which demonstrated to us that the Radixact System is a viable mainstream radiation therapy option capable of providing advanced treatments to a high volume of patients."
The Radixact System is designed to be a highly reliable radiation therapy device that offers clinicians the opportunity to improve the cancer treatment experience throughout a patient's treatment journey, including when retreatment is necessary.
The system features a more powerful linear accelerator, low-dose fan beam megavoltage computed tomography (MVCT) imaging and unique helical delivery technology, facilitating highly conformal and homogenous dose distributions to any target volume, while sparing normal healthy tissue, during each treatment fraction.
The next-generation treatment delivery software, control systems, service tools and hardware components significantly increase the ease and speed and efficiency with which clinical teams can provide radiation treatments.
A fully-integrated, simplified adaptive treatment planning solution informs precise treatment planning and mid-course decision-making, enabling the clinical team to adapt therapy to changes in tumor size, shape and location — as well as subtle changes in the location of organs and other healthy tissue.
For more information: www.accuray.com
July 11, 2024 
